Use of a genetically engineered protein for the design of a multivalent MRI contrast agent

Bioconjugate Chemistry

Volumn 18, Issue 6, 2007, Pages 1697-1700

  Karfeld, Lindsay S ^a   Bull, Steve R ^b   Davis, Nicolynn E ^a   Meade, Thomas J ^b,c   Barron, Annelise E ^a,b,d  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; CROSSLINKING; GADOLINIUM COMPOUNDS; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; PROTEINS; SCAFFOLDS (BIOLOGY);

CONTRAST AGENT; GADOLINIA; GENETICALLY ENGINEERED PROTEIN; MRI CONTRAST AGENTS; POLYMER BASED; PROTEIN BACKBONE; PROTEIN LENGTH; PROTEIN POLYMERS; RELAXIVITY; SIGNAL ENHANCEMENT;

CHELATION;

GADOLINIUM; LYSINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYMER;

AMINO ACID SEQUENCE; ARTICLE; CONJUGATION; CONTRAST ENHANCEMENT; COVALENT BOND; CROSS LINKING; GENETIC ENGINEERING; HYDROGEL; PYRIMIDINE SYNTHESIS;

EID: 36849070225     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc700149u     Document Type: Article

References (32)

1. Yang, S. F., Leong, K. F., Du, Z. H., and Chua, C. K. (2001) The design of scaffolds for use in tissue engineering. Part 1. Traditional factors. Tissue Eng. 7, 679-689.
2. Langer, R., and Tirrell, D. A. (2004) Designing materials for biology and medicine. Nature (London) 428, 487-492.
3. Liu, W., and Chen, C. (2005) Engineering biomaterials to control cell function. Mater. Today 8, 28-35.
4. Discher, D. E., Janmey, P., and Wang, Y. L. (2005) Tissue cells feel and respond to the stiffness of their substrate. Science 310, 1139-1143.
5. Pihlajamaki, H., Kinnunen, J., and Bostman, O. (1997) In vivo monitoring of the degradation process of bioresorbable polymeric implants using magnetic resonance imaging. Biomaterials 18, 1311-1315.
6. Neves, A. A., Medcalf, N., Smith, M., and Brindle, K. M. (2006) Evaluation of engineered meniscal cartilage constructs based on different scaffold geometries using magnetic resonance imaging and spectroscopy. Tissue Eng. 12, 53-62.
7. Bull, S., Guler, M., Bras, R., Venkatasubramanian, P., Stupp, S., and Meade, T. (2005) Magnetic resonance imaging of self-assembled biomaterial scaffolds. Bioconjugate Chem. 16, 1343-1348.
8. Cheery, S. (2004) In vivo molecular and genomic imaging: new challenges for imaging physics. Phys. Med. Biol. 49, R13-R48.
9. Huber, M., Staubli, A., Kustedjo, K., Gray, M., Shih, J., Fraser, S., Jacobs, R., and Meade, T. (1998) Fluorescently detectable magnetic resonance imaging agents. Bioconjugate Chem. 9, 242-249.
10. Watanabe, T. (2002) Recent topics in NMR imaging and MRI. Magn. Reson. Med. Sci. 1, 38-49.
11. Bull, S. R., Guler, M. O., Bras, R. E., Meade, T. J., and Stupp, S. I. (2005) Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents. Nano Lett. 5, 1-4.
12. Artemov, D., Bhujwalla, Z., and Bulte, J. (2004) Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr. Pharm. Biotechnol. 5, 485-494.
13. Merbach, A. E., and Toth, E. (2001) The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. John Wiley & Sons, Inc., West Sussex, England.
14. Caravan, P., Ellison, J., McMurry, T., and Lauffer, R. (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293-2352.
15. Sirlin, C., Vera, D., Corbell, J., Caballero, M., Buxton, R., and Mattrey, R. (2004) Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad. Radiol. 11, 1361-1169.
16. Opsahl, L., Uzgiris, E., and Vera, D. (1995) Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine- polylysine. Acad. Radiol. 2, 762-767.
17. Langereis, S., de Lussanet, Q., van Genderen, M., Meijer, E., Beets-Tan, R., Griffioen, A., van Engelshoven, J., and Backes, W. (2006) Evaluation of Gd(III)DTPA-terminated polypropylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed. 19, 133-141.
18. Anderson, E. A., Isaacman, S., Peabody, D. S., Wang, E. Y., Canary, J. W., and Kirshenbaum, K. (2006) Viral nanoparticles donning a paramagnetic coat: Conjugation of MPJ contrast agents to the MS2 capsid. Nano Lett. 6, 1160-1164.
19. Strijkers, G., Mulder, W., van Heeswijk, R., Frederik, P., Bomans, P., Magusin, P., and Nicolay, K. (2005) Relaxivity of liposomal paramagnetic MRI contrast agents. Magma 18, 186-192.
20. Stroman, P. W., Dorvil, J. C., Marois, Y., Poddevin, N., and Guidoin, R. (1999) In vivo time course studies of the tissue responses to resorbable polylactic acid implants by means of MRI. Magn. Reson. Med. 42, 210-214.
21. Traore, A. S., Woerly, S., Doan, V. D., Marois, Y., and Guidoin, R. (2000) In vivo magnetic resonance imaging and relaxometry study of a porous hydrogel implanted in the trapezius muscle of rabbits. Tissue Eng. 6, 265-278.
22. Barbash, I. M., Leor, J., Feinberg, M. S., Tessone, A., Aboulafia-Etzion, S., Orenstein, A., Ruiz-Cabello, J., Cohen, J. S., and Mardor, Y. (2004) Interventional magnetic resonance imaging for guiding gene and cell transfer in the heart. Heart 90, 87-91.
23. Cheng, H. L. M., Chen, J., Babyn, P. S., and Farhat, W. A. (2005) Dynamic Gd-DTPA enhanced MRI as a surrogate marker of angiogenesis in tissue-engineered bladder constructs: A feasibility study in rabbits. J. Magn. Reson. Imaging 21, 415-423.
24. Davis, N., Ding, S., Karfeld, L., and Barron, A. (2007). Synthesis and characterization of a new class of cationic protein polymers for multivalent display and biomaterial applications. Unpublished results.
25. Won, J., and Barron, A. (2002) A new cloning method for the preparation of long repetitive polypeptides without a sequence requirement. Macromolecules 35, 8281-8287.
26. Artemov, D., Mori, N., Okollie, B., and Bhujwalla, Z. (2003) MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn. Reson. Med. 49, 403-408.
27. Ausbel, F. (2001) Current Protocols in Molecular Biology, J. Wiley & Sons, Inc., New York.
28. Hermanson, G. (1996) Bioconjugate Chemistry, Academic Press, San Diego.
29. Kobayashi, H., and Brechbiel, M. W. (2004) Dendrimer-based nanosized MRI contrast agents. Curr. Pharm. Biotechnol. 5, 539-549.
30. Mikawa, M., Kato, H., Okumura, M., Narazaki, M., Kanazawa, Y., Miwa, N., and Shinohara, H. (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem. 12, 510-514.
31. Allen, M., Bulte, J., Liepold, L., Basu, G., Zywicke, H., Frank, J., Young, M., and Douglas, T. (2005) Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn. Reson. Med. 54, 807-812.
32. Aime, S., Frullano, L., and Crich, S. G. (2002) Compartmentalization of a gadolinium complex in the apoferritin cavity: A route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew. Chem., Int. Ed. 41, 1017-1019.